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Abstract
Background—Sexually transmitted diseases (STDs) including chlamydia and gonorrhea, cause 
pelvic inflammatory disease and infertility. We estimated the prevalence of infertility and 
infertility healthcare seeking.
Methods—We analyzed self-reported lifetime infertility and infertility healthcare-seeking in 
women aged 18–49 years in the 2013 and 2015 National Health and Nutrition Examination 
Surveys. Weighted prevalence of infertility and infertility healthcare seeking, prevalence ratios 
(PRs), and 95% confidence intervals (CIs) were calculated.
Results—Among 2,626 eligible women, 13.8% had self-reported infertility [95% CI 12.3–15.3] 
with higher prevalence by age: 6.4% [95% CI 4.8–8.0], n=960 18–29 year olds; 14.8% [95 % CI 
12.2–17.3], n=799 30–39 year olds; and 20.8% [95% CI 17.2–24.4], n=867 40–49 year olds. Non-
Hispanic white women (15.4% [95% CI 13.0–17.8]; n=904) and non-Hispanic black women 
(12.9% [95% CI 10.3–15.5]; n=575) had the highest infertility prevalences. Women reporting PID 
treatment (n=122) had higher infertility prevalence (24.2% [95% CI 16.2–32.2]) than women 
without PID treatment (13.3% [95% CI 11.6–15.0], n=2,485), especially among 18–29 year old 
women (PR 3.8 [95% CI 1.8–8.0)]. Of 327 women with infertility, 60.9% (95% CI 56.1–65.8) 
sought healthcare. Women without healthcare insurance sought care less frequently than women 
with insurance.
Conclusions—In a nationally-representative sample, 13.8% of reproductive-age women 
reported a history of infertility, of whom 40% did not access healthcare. Self-reported PID was 
associated with infertility, especially in young women. Annual chlamydia and gonorrhea screening 
to avert PID may reduce the burden of infertility in the US.
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Of the 13.8% of reproductive-age women reporting any lifetime infertility, 40% did not access 
healthcare. Self-reported pelvic inflammatory disease was associated with infertility, especially 
among young women.
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Introduction
Infertility, or the inability to conceive a child in a 12-month period, affected an estimated 
6.7% of women in the United States during 2011–2015(1) and can be associated with 
psychosocial morbidity, including depression and anxiety(2, 3). Healthcare costs associated 
with treatment for infertility can be considerable, given that a cycle of in vitro fertilization 
(IVF) is estimated to cost $12,400(4). Female factors in infertility include oocyte aging, 
ovulatory disorders, tubal and uterine factors (e.g. tubal damage, pelvic adhesions, and 
endometriosis), and other factors(5).
Tubal factor infertility (TFI) is often caused by sexually transmitted diseases (STDs), 
notably chlamydia and gonorrhea. These infections may lead to symptomatic or 
asymptomatic pelvic inflammatory disease (PID) characterized by tubal inflammation and 
scarring. In the 1980s chlamydia surpassed gonorrhea as the organism most commonly 
isolated from women with PID(6). Historically, up to 5% of untreated chlamydial infections 
cause PID in the first few weeks after infection(7). In the year after untreated chlamydia 
infection, 9.5% of women developed PID(8); however, as many as 30% of women have 
developed PID after concurrent gonococcal and chlamydial infection(9). Once women have 
PID, up to 15–20% subsequently develop infertility(7) with a large proportion of this 
infertility being TFI(10).
Infertility due to STDs is preventable. To this end, public health agencies have supported 
programs to improve STD prevention and early detection(11). Current data on the 
epidemiology of infertility may help to guide public health efforts. Questions about 
infertility were first included in the National Health and Nutrition Examination Survey 
(NHANES) in the 2013–2014 cycle. We estimate the prevalence of self-reported lifetime 
infertility and infertility healthcare seeking in a nationally representative sample from the 
2013–2016 cycles of NHANES to describe the current epidemiology of infertility in the 
United States.
Materials and Methods
NHANES is a cross-sectional, nationally-representative, complex, multistage survey to 
assess the general health status of the non-institutionalized U.S. population(12). Consenting 
participants complete an interview questionnaire, undergo a physical exam, and submit 
biological specimens for laboratory tests.
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We analyzed data from the 2013–2014 and 2015–2016 NHANES cycles from women of 
reproductive age (18–49 years of age) who were sexually-experienced (defined as reporting 
ever having had vaginal sexual intercourse with a man) to determine the weighted lifetime 
prevalence of self-reported infertility. A lifetime history of infertility was defined as a ‘yes’ 
answer to the question: ‘Have you ever attempted to become pregnant over a period of at 
least a year without becoming pregnant?’. We also assessed healthcare seeking behavior 
among women who reported a history of infertility, by the question: ‘Have you ever been to 
a doctor or other medical provider because you have been unable to become pregnant?’. 
Hispanic ethnicity was defined for women who reported being Mexican American or those 
who reported being ‘other Hispanic’.
We analyzed demographic characteristics and characteristics obtained from interview 
(including (A) self-reported history of chlamydia or gonorrhea in the past 12 months, (B) 
history of an STD diagnosis [chlamydia or gonorrhea in the past 12 months or having been 
told of a herpes, genital warts, or human papillomavirus diagnosis], (C) self-reported history 
of PID treatment), and (D) laboratory factors, including results of Chlamydia trachomatis or 
Trichomonas vaginalis nucleic acid amplification testing (NAAT)(13) from a urine specimen 
collected at the time of exam.
To account for the complex survey design, we used provided sampling weights and 
estimated the weighted prevalence of infertility and infertility healthcare seeking with 95% 
confidence intervals (CI) for the combined 2013–2014 and 2015–2016 cycles. Furthermore, 
we estimated the prevalence ratios (PR) with 95% CI to compare the prevalence of infertility 
among subgroups of interest (e.g., age group, race/ethnicity, and women with STDs or PID).
P-values were calculated using the Rao-Scott chi-square test. We set a statistical significance 
level at a P-value of less than 0.05. Relative standard errors (RSE) were calculated. A 
calculated RSE of greater than 30% was highlighted because this value is potentially 
unreliable and should be interpreted with caution per NHANES guidance(14).
The primary NHANES protocol has National Center for Health Statistics Ethics Review 
Board approval. Informed consent is sought from participants, and data from NHANES are 
publically available, thus no additional review was required before obtaining the data and 
conducting the analysis(12).
Results
Study sample
Overall, 10,251 women were included from the 2013–2014 and 2015–2016 NHANES 
cycles (mobile exam response rate ranged from: 58.9–77.1%(15)). Of these, 3,423 (33.4%) 
were of reproductive age (18–49 years of age), 3,304 (96.5%) of these women completed an 
interview and physical exam, and 2,631 (79.6%) reported being sexually-experienced. Our 
analytic sample included the 2,626 (99.8%) sexually-experienced women 18–49 years of age 
who provided an answer to the question on lifetime history of infertility.
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Prevalence of lifetime infertility
The weighted prevalence of self-reported lifetime infertility was 13.8% (95% CI 12.3–15.3) 
(Table 1) among 2,626 women in the 2013–2016 cycles of NHANES and was similar in 
each of the two cycles (14.7% [95% CI 12.3–17.0] in 2013–2014 and 12.9% [95% CI 11.1–
14.8] in 2015–2016). Infertility prevalence increased by age group: the prevalence among 
women 40–49 years of age was 3.3 times the prevalence (95% CI 2.3–4.5) among women 
18–29 years of age (Table 1). By race/ethnicity, non-Hispanic white women (15.4% [95% CI 
13.0–17.8]) and non- Hispanic black women (12.9% [95% CI 10.3–15.5]) had the highest 
infertility prevalences, followed by Hispanic women (10.9% [95% CI 8.7–13.1]). Compared 
to non-Hispanic white women, Hispanic women had a statistically significantly lower 
infertility prevalence (PR 0.7 [95% CI 0.5–1.0], p=0.03), whereas for non-Hispanic Asian 
women this comparison approached statistical significance (PR 0.7 [95% CI 0.5–1.0], 
p=0.06) (Table 1). Women with higher incomes and greater educational attainment reported 
infertility more often than women with lower incomes and less education (Table 1).
Overall, the prevalence of infertility did not significantly differ by having had a chlamydia 
diagnosis in the past 12 months, or Chlamydia trachomatis or Trichomonas vaginalis NAAT 
positivity at the time of exam (Table 1). The prevalence of infertility among women who 
reported a prior STD diagnosis was 17.1% (95% CI 13.1–21.1) and 13.0% (95% CI 11.2–
14.7) for those without a prior STD. Overall, women who reported a history of PID 
treatment had an infertility prevalence of 24.2% (95% CI 16.2–32.2), which was 1.8 times 
the prevalence among women with no history of PID treatment (13.3% [95% CI 11.6–15.0]) 
(Table 1).
Among women 18–29 years of age, Hispanic and non-Hispanic black women had the 
highest prevalences of infertility (10.0% [95% CI 6.2–13.8%] and 10.6% [95% CI 6.7–
14.5%], respectively). Among women 40–49 years of age, non-Hispanic white and non-
Hispanic Asian women had the highest infertility prevalences (24.6% [95% CI 19.3–29.8] 
and 16.0% [95% CI 10.2–21.9], respectively. (Figure 1). In looking at history of PID 
treatment among age groups, the difference in infertility prevalence between women with 
and without reported histories of PID treatment was most pronounced among 18–29 year old 
women (PR 3.8 [95% CI 1.8–8.0]; 22.1% [95% CI 6.9–37.3] versus 5.8% [95% CI 4.3–7.2] 
respectively) (Figure 2).
Prevalence of infertility healthcare seeking
Among the 327 women who self-reported infertility, the weighted prevalence of reporting 
ever having sought healthcare for infertility was 60.9% (95% CI 56.1–65.8). There was no 
difference in the prevalence of healthcare seeking between the 2013–2014 and 2015–2016 
cycles.
By age group, infertile women 18–29 years of age had the lowest prevalence of seeking care 
for infertility (33.9%) and infertile women 30–39 years of age had the highest prevalence 
(70.8%) (PR 2.1 [95% CI 1.4–3.0]) (Table 2). Non-Hispanic black women were less likely to 
seek infertility-related healthcare than non-Hispanic white women (PR 0.7 [95% CI 0.5–
0.8]). Women with the lowest family incomes were less likely to seek care than women with 
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the highest incomes (41.8% ([95% CI 29.6–54.1]) vs. 71.5% [95% CI 64.5–78.6], 
respectively). Women with health insurance were more likely to have sought care than 
women without insurance (64.3% [95% CI 58.9–69.7] vs. 45.4% [95% CI 35.5–55.3]) 
(Table 2).
Discussion
In this first assessment of the population-based prevalence of infertility using nationally-
representative data from NHANES, we found that nearly 14% of U.S. women aged 18–49 
years during 2013–2016 had a self-reported lifetime history of infertility. We found the 
prevalence of infertility was highest among women who were older, were non-Hispanic 
white, and who reported higher incomes or educational attainment. The prevalence of 
infertility was also higher in women with a history of PID treatment compared to those 
without PID treatment. Among young women, Hispanic and non-Hispanic black women had 
the highest prevalence of infertility whereas among the oldest women, non-Hispanic white 
women had the highest prevalence of infertility.
We found that self-reported PID treatment was associated with self-reported infertility, and 
that this association was most pronounced among young women. Among 18–29 year old 
women, a history of PID was associated with a fourfold higher prevalence of reported 
infertility. Chlamydia and gonorrhea, the most common known causes of PID, are reported 
most frequently in young women 15–24 years of age in the U.S.(16). PID has also been 
found more frequently in young women 20–24 years old in select populations(17, 18). 
Although we did not observe an association between self-reported infertility and a self-
reported history of chlamydia or gonorrhea, it is possible that this lack of association may be 
due to underreporting of these often asymptomatic and potentially undiagnosed STDs. 
Additionally, other sexually transmitted microorganisms besides chlamydia and gonorrhea, 
including Mycoplasma genitalium, Ureaplasmas, T. vaginalis, and proliferated organisms in 
the vaginal microbiome have been implicated in the development of PID(6, 19). 
Trichomonas has specifically been shown to be related to PID development among women 
with HIV(20). However, more research into the etiology of PID and the potential role of 
various pathogens and conditions, such as T. vaginalis and bacterial vaginosis, in causing 
PID and infertility is needed. The high incidence of STDs and PID in young women along 
with the observed significant relationship between PID and prevalence of infertility suggest 
that STDs and subsequent PID could be a major reason for infertility in young women. 
These data serve as reminders that PID-associated infertility can affect young women.
It is possible that we did not see an association between PID and infertility in older women 
because of the occurrence of non-PID related infertility in addition to TFI in this age group. 
Another challenge that may preclude seeing an association between STDs, lifetime PID, and 
lifetime infertility in older women in particular in this cross-sectional analysis is that each of 
these factors may not have occurred in the expected temporal sequence such that exposure to 
STDs and subsequent PID occurred prior to experiencing a period of infertility.
The epidemiology of lifetime infertility by race/ethnicity in our sample differs somewhat 
from what has previously been described, hinting at a changing epidemiology. Whereas we 
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found that prevalence of infertility was not significantly different between non-Hispanic 
white women and non-Hispanic black women, prior work demonstrated that non-Hispanic 
black women had a higher prevalence of current infertility compared to non-Hispanic white 
women(21, 22). In 2006–2010 data from the National Survey of Family Growth (NSFG) 
among married and cohabiting women aged 22–44 years, non-Hispanic black women were 
more likely (adjusted odds ratio 1.8 [95% CI 1.1–3.1]) to report current infertility (lack of 
pregnancy in prior 12 months despite condomless intercourse with a man each month) 
compared to non-Hispanic white women(23). However, methodological differences may 
account for the differing results given that Chandra et al. assessed current infertility versus 
lifetime infertility and used multivariable regression modeling to adjust for age, parity, 
marital or cohabiting status, education, and poverty.
In addition to the overall difference in infertility prevalence comparing Non-Hispanic white 
to Hispanic women, we found differing infertility prevalences across age groups. Our 
observation that the epidemiology of infertility by race/ethnicity differs among age groups 
and that PID seems to be a contributing factor among the youngest women suggests that 
there may be differing factors contributing to infertility among different age groups. In the 
youngest women, where we see that PID is related to lifetime infertility, differing 
epidemiology of PID among race/ethnicity groups may contribute more to differing 
prevalences of infertility by race. Among older women where PID does not appear to be a 
main factor in infertility, other explanations for differing infertility prevalences among race/
ethnicity groups, such as deferred child bearing because of education or employment 
opportunities, might play a role given reported differences in delayed child bearing by race/
ethnicity(24). Further epidemiological investigations to understand differences in the 
epidemiology of infertility by age and race are warranted.
Nearly 40% of women who self-reported infertility did not seek healthcare services for 
infertility. Notably, women without health insurance were significantly less likely to seek 
infertility services than women with insurance. While we could not explore specific reasons 
that women did not seek infertility-related healthcare, it may be that lower socioeconomic 
status and lack of insurance establish sufficient barriers to care, particularly in light of the 
considerable economic costs of infertility treatment(4).
Our analysis had limitations. Owing to the cross-sectional and self-reported nature of the 
data, we cannot determine the temporal relationship between PID and infertility. We are thus 
limited in our ability to draw causal inferences. Our sample size prevented additional 
analyses requiring further stratifications, such as by age group, race/ethnicity, and history of 
PID treatment thus we did not perform a multivariable analysis or report on additional 
multilevel stratifications that would be ideal to account for confounding factors. In our 
analysis, we did not find overall differences in infertility prevalence among women with a 
history of selected STDs or with chlamydia or gonorrhea diagnosis in the last 12 months. 
The absence of the inclusion of any laboratory test for past infection (e.g. serology) or 
reported history of chlamydia or gonorrhea exposure before the preceding 12 months within 
NHANES limits our ability to assess for a relationship with these major contributors to PID 
and a lifetime self-reported episode of infertility.
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Using nationally-representative data collected during 2013–2016, we found that 13.8% or 
nearly 1 in 7 U.S. women reported a lifetime history of infertility and almost two-thirds 
sought infertility treatment. Among women who reported a history of PID treatment, nearly 
25% experienced infertility. To prevent PID and PID-associated infertility, healthcare 
providers are encouraged to follow Centers for Disease Control and Prevention and United 
States Preventive Services Task Force recommendations for annual chlamydia and 
gonorrhea screening for all women younger than 25 years old, and women with high-risk 
behaviors older than 25 years(19, 25). Ensuring access to screening and following 
recommendations for annual chlamydia and gonorrhea screening may reduce PID-related 
infertility. These data serve as reminders of the important reproductive health sequelae of 
bacterial STDs. We hope that these findings reinvigorate efforts to better understand the 
epidemiology and etiology of PID and infertility, and to reinforce approaches to avert 
preventable causes of infertility.
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Figure 1. Prevalence of self-reported infertility among sexually-experienced women aged 18–49 
years by age and race-ethnicity, National Health and Nutrition Examination Survey, 2013–20161
1Based on initial sample size of N=2,509. Women of other or multirace categories (n=117) 
are excluded because of small sample size.
* Statistically significant difference from non-Hispanic white women (p<0.05, Rao-Scott 
chi-square)
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Figure 2. Prevalence of self-reported infertility among sexually-experienced women aged 18–49 
years by age and PID1 treatment history, National Health and Nutrition Examination Survey, 
2013–20162
1PID: Pelvic inflammatory disease
2Based on initial sample size of N=2,607. Women without available data for PID treatment 
are excluded (n=19).
* Infertility prevalence ratio for PID to no PID is 3.8 (95% CI 1.8–8.0), p<0.01. Relative 
standard error > 30% for infertility prevalence among 18–29 year old women with PID
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Table 2:
Prevalence of seeking care for infertility1 among sexually-experienced women aged 18–49 years with reported 
history of infertility, by selected characteristics, National Health and Nutrition Examination Survey, 2013–
2016 (N=3272)
Characteristic Category Sample size Weighted
prevalence3
(%)
Weighted 
prevalence3 
95% CI4
Weighted
prevalence
ratio5
Weighted 
prevalence 
ratio5 95% 
CI4
TOTAL 327 60.9 56.1–65.8
Age (years) 18–29 69 33.9 23.1–44.8 REF REF
30–39 106 70.8 60.8–80.8 2.1 1.4–3.0
40–49 152 63.3 57.2–69.4 1.9 1.3–2.6
Race and Hispanic origin Non-Hispanic White 132 64.8 58.4–71.1 REF REF
Non-Hispanic Black 71 42.7 34.2–51.2 0.7 0.5–0.8
Hispanic6 79 50.0 37.5–62.5 0.8 0.6–1.0
Non-Hispanic Asian 30 87.0 79.1–94.9 1.3 1.2–1.5
Other or Multi-Racial 15 70.5 50.8–90.3 1.1 0.8–1.4
Ratio of family income to 
poverty level7
<1.5 113 41.8 29.6–54.1 REF REF
1.5–3 74 61.5 52.4–70.6 1.5 1.0–2.2
>=3 124 71.5 64.5–78.6 1.7 1.3–2.3
Marital status Never married 47 45.9 32.0–59.8 REF REF
Divorced, widowed, separated 43 56.8 42.3–71.3 1.2 0.8–1.9
Married 233 63.9 57.8–70.0 1.4 1.0–2.0
Education <High school 43 33.8 18.6–48.9 0.5 0.3–0.7
High school graduate/General 
education diploma
61 43.8 28.4–59.1 0.6 0.4–0.9
Some college/Associate’s degree 130 62.5 54.3–70.7 0.8 0.7–1.0
> College graduate 93 74.1 65.8–82.4 REF REF
Ever had PID8 treatment Yes 28 51.6 29.8–73.4 0.8 0.5–1.3
No 296 61.5 56.2–66.8 REF REF
Previous STD9 diagnosis Yes 67 63.4 51.3–75.4 1.1 0.8–1.3
No 260 60.1 54.1–66.1 REF REF
Told had chlamydia in past 
12 months10
Yes 8 31.2 11.4–51.1 0.5 0.3–1.0
No 319 61.6 56.8–66.5 REF REF
Told had gonorrhea in past 
12 months
Yes 0 NA NA NA NA
No 327 NA NA NA NA
Urine Chlamydia NAAT11 
result12
Positive 4 25.5 (0.0–68.5) 0.4 (0.08–2.4)
Negative 169 59.5 (51.7–67.3) REF REF
Urine Trichomonas NAAT 
result10
Positive 20 21.1 (0.9–41.2) 0.3 (0.1–0.9)
Negative 304 62.9 (58.1–67.6) REF REF
Ever pregnant Yes 277 63.5 (58.0–69.1) 1.4 (1.0–2.1)
No 45 44.5 (28.8–60.2) REF REF
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Characteristic Category Sample size Weighted
prevalence3
(%)
Weighted 
prevalence3 
95% CI4
Weighted
prevalence
ratio5
Weighted 
prevalence 
ratio5 95% 
CI4
TOTAL 327 60.9 56.1–65.8
Ever used birth control pills Yes 254 63.5 (57.9–69.2) 1.3 (1.0–1.7)
No 73 49.2 (37.6–60.7) REF REF
Health insurance coverage Yes 252 64.3 58.9–69.7 1.4 1.1–1.8
No 74 45.4 35.5–55.3 REF REF
Routine place for healthcare Yes 287 63.9 57.9–70.0 REF REF
No 40 37.8 18.8–56.8 0.6 0.3–1.0
1
Prevalence estimates based on response to the question “Have you … ever been to a doctor or other medical provider because you have … been 
unable to become pregnant?”
2Variables with missing data include: Ratio of family income to poverty level (n=16); Marital status (n=4)
3
Estimates were weighted to be nationally representative of the U.S. population, accounting for unequal probabilities of selection and nonresponse.
4CI: Confidence interval
5
Respondents with missing or unknown values were excluded from prevalence ratio calculations
6
Hispanic ethnicity includes Mexican American and other Hispanic ethnicity
7
Poverty level as defined by the Department of Health and Human Services
8
PID: Pelvic inflammatory disease
9
Previous STD (Sexually transmitted disease) includes chlamydia or gonorrhea in the last 12 months or ever being told of a herpes, genital warts, 
or human papillomavirus diagnosis
10
Relative standard error is > 30% and <50%
11NAAT: Nucleic acid amplification test
12
Relative standard error is > 30% and <50%
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